Brazilian Critical Minerals Issues 8.4 Million Shares Following BCMAF Option Exercise at $0.011 Each

BCMAF Options Exercised at $0.011 Result in New Ordinary Shares

On 1 July 2026, Brazilian Critical Minerals Limited lodged an Appendix 2A with ASX, applying for the quotation of 8,395,832 new fully paid ordinary shares issued through the exercise of BCMAF options. These options carry an exercise price of $0.011 per option and expire on 12 August 2027. The last exercise date for these options was recorded as 1 July 2026.

The exercise price of $0.011 per share means the company received cash consideration in Australian dollars for each option exercised. Based on the number of options converted and the exercise price, the gross proceeds from this conversion are approximately $92,354, although the company did not disclose net proceeds in this update. The newly issued shares are intended to be quoted on ASX and rank equally with existing BCM ordinary shares from their issue date of 1 July 2026.

Total BCM Ordinary Shares Now Close to 1.97 Billion

Following the listing of this tranche of shares, Brazilian Critical Minerals’ total quoted ordinary shares amount to 1,969,019,998. This figure is generated automatically by ASX systems during the Appendix 2A filing process. The company noted that these numbers may not fully represent its current issued capital if other filings are being processed concurrently.

This milestone is significant for investors tracking the company’s capital structure. Share counts approaching 2 billion are typical for early-stage ASX-listed explorers, where ongoing capital raises, option issuances, and conversions are common methods to fund exploration. The gradual conversion of outstanding options allows holders to realise their positions while providing the company with incremental working capital.

Remaining 104.6 Million BCMAF Options Present Potential Dilution

Despite the recent conversion, 104,595,830 BCMAF options remain unexercised and unquoted, all with the same $0.011 exercise price and 12 August 2027 expiry. This leaves open the possibility of further share issuances if holders exercise these options before expiry.

If all remaining BCMAF options were exercised at $0.011, the company could raise approximately $1.15 million in gross proceeds, increasing the ordinary share count accordingly. Investors should consider this potential dilution, although the timing and likelihood of exercise depend on market conditions and BCM’s share price relative to the exercise price. The company did not provide guidance on expected exercise timelines in this update.

Brazilian Critical Minerals’ Unquoted Securities Register Post-Conversion

The Appendix 2A filing also details the company’s unquoted securities as of this update. Besides the 104,595,830 BCMAF options remaining, the company holds several other unquoted securities: 89,225,000 BCMAD options expiring 23 December 2027 at $0.0175 exercise price; 89,600,000 BCMAB performance rights; 3,000,000 BCMAA options expiring 20 December 2026 at $0.05 exercise price; 50,000,000 BCMAG options expiring 1 October 2028 at $0.04 exercise price; and 50,000,000 BCMAE options expiring 15 December 2028 at $0.0175 exercise price.

Collectively, these unquoted securities represent a significant potential source of future share issuances and cash inflows if options are exercised. Performance rights convert to shares upon meeting performance conditions without cash payment; however, the company did not provide details on these conditions in this update. Investors should consider the full range of these securities when evaluating BCM’s potential future share count.

Original Structure and Issuance of BCMAF Options

The BCMAF options, formally titled "OPTION EXPIRING 12-AUG-2027 EX $0.011," are one of several option tranches issued by Brazilian Critical Minerals as part of its capital and incentive management. These options were not issued under an employee incentive scheme, unlike the BCMAB performance rights which may have different vesting and conversion terms.

The low exercise price of $0.011 reflects market conditions at the time of issuance, consistent with the low single-cent trading ranges typical for early-stage ASX mineral explorers. The commencement of option exercises indicates that market conditions have made conversion financially attractive for some holders. The company did not disclose the identities or nature of the exercising holders in this update.

Sector Context for BCM Investors

As its name suggests, Brazilian Critical Minerals focuses on critical minerals projects in Brazil. Critical minerals, essential for batteries, defence, and clean energy supply chains, have attracted significant global investor and government interest. Australia and Brazil are recognised as key potential suppliers. BCM’s ASX listing situates it within a sector marked by substantial capital flows and speculative interest, though outcomes vary widely based on project quality, management, and commodity cycles.

Option exercises and share issuances, while dilutive, are standard for companies at BCM’s development stage and do not by themselves indicate operational milestones. Investors seeking insight into exploration progress, resource updates, or strategic direction should consult the company’s broader project announcements and quarterly reports, which provide operational details beyond routine securities filings.

New Shares Have Equal Rights with Existing BCM Shares

The Appendix 2A confirms that the 8,395,832 newly issued shares rank equally in all respects with existing BCM ordinary shares from their issue date of 1 July 2026. This ensures that those who exercised BCMAF options hold shares with identical economic and voting rights, including entitlement to dividends, capital returns, or corporate actions.

Equal ranking is a standard ASX Listing Rules requirement, assuring shareholders there is no preferential treatment. Given the small size of this tranche relative to the nearly 1.97 billion shares on issue, the immediate impact on existing shareholders’ proportional holdings is minimal, though cumulative conversions over time may have a more significant effect.

Upcoming BCMAA Option Expiry in December 2026 Marks Next Capital Event

Following the BCMAF conversion, the next key date is the expiry of the BCMAA options—3,000,000 options expiring 20 December 2026 with a $0.05 exercise price. This is substantially higher than the BCMAF price, so holders’ decision to exercise will depend on BCM’s share price performance before expiry.

Beyond 2026, multiple option tranches extend into 2027 and 2028, including 89,225,000 BCMAD options and 50,000,000 each of BCMAE and BCMAG options. These represent significant milestones on BCM’s unquoted securities calendar. Investors and analysts should monitor whether operational progress supports share prices sufficient to incentivise exercise of higher-priced options.

Share Price Impact and Investor Focus

The immediate impact of this update on BCM’s share price is unclear. Routine option exercises and share listings like this are generally anticipated and do not typically trigger significant price moves. Market reaction, if any, will depend on broader sentiment toward BCM and the critical minerals sector at the time.

Investors are likely focused on substantial operational developments such as exploration results, resource updates, or partnership and funding announcements related to BCM’s Brazilian projects, which have more direct influence on share price. The next capital structure event is the BCMAA option expiry in December 2026, while operational updates are expected in forthcoming quarterly reports.